-
1Editorial & Opinion
المؤلفون: Lele RD
المصدر: The Journal of the Association of Physicians of India [J Assoc Physicians India] 2005 Aug; Vol. 53, pp. 671-5.
نوع المنشور: Editorial
بيانات الدورية: Publisher: Association of Physicians of India Country of Publication: India NLM ID: 7505585 Publication Model: Print Cited Medium: Print ISSN: 0004-5772 (Print) Linking ISSN: 00045772 NLM ISO Abbreviation: J Assoc Physicians India Subsets: MEDLINE
مواضيع طبية MeSH: Physicians*, Commerce/*legislation & jurisprudence , Drug Industry/*legislation & jurisprudence , Patents as Topic/*legislation & jurisprudence, Attitude of Health Personnel ; Developing Countries ; Drugs, Essential/economics ; Drugs, Essential/supply & distribution ; Humans ; India ; International Agencies
-
2أخبار
المصدر: AIDS policy & law [AIDS Policy Law] 2007 Aug 24; Vol. 22 (16), pp. 2.
نوع المنشور: Newspaper Article
بيانات الدورية: Publisher: Buraff Publications Country of Publication: United States NLM ID: 8703425 Publication Model: Print Cited Medium: Print ISSN: 0887-1493 (Print) Linking ISSN: 08871493 NLM ISO Abbreviation: AIDS Policy Law
مواضيع طبية MeSH: Drug Industry* , Patents as Topic*, Drugs, Essential ; India ; International Cooperation
-
3دورية أكاديمية
المؤلفون: Mueller JM; University of Pittsburgh School of Law, Pittsburgh, USA.
المصدر: The New England journal of medicine [N Engl J Med] 2007 Feb 08; Vol. 356 (6), pp. 541-3.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
مواضيع طبية MeSH: Legislation, Drug*, Drug Industry/*legislation & jurisprudence , Health Services Accessibility/*legislation & jurisprudence , Patents as Topic/*legislation & jurisprudence, Antineoplastic Agents/economics ; Benzamides ; Developing Countries ; Drug Costs ; Drug Industry/economics ; Drugs, Essential/economics ; Drugs, Generic ; Humans ; Imatinib Mesylate ; India ; Licensure/legislation & jurisprudence ; Piperazines/economics ; Pyrimidines/economics